134 related articles for article (PubMed ID: 18032925)
1. Notch and Ikaros: not only converging players in T cell leukemia.
Bellavia D; Mecarozzi M; Campese AF; Grazioli P; Gulino A; Screpanti I
Cell Cycle; 2007 Nov; 6(22):2730-4. PubMed ID: 18032925
[TBL] [Abstract][Full Text] [Related]
2. Notch3 and the Notch3-upregulated RNA-binding protein HuD regulate Ikaros alternative splicing.
Bellavia D; Mecarozzi M; Campese AF; Grazioli P; Talora C; Frati L; Gulino A; Screpanti I
EMBO J; 2007 Mar; 26(6):1670-80. PubMed ID: 17332745
[TBL] [Abstract][Full Text] [Related]
3. Ikaros regulates Notch target gene expression in developing thymocytes.
Chari S; Winandy S
J Immunol; 2008 Nov; 181(9):6265-74. PubMed ID: 18941217
[TBL] [Abstract][Full Text] [Related]
4. Oncogenic activation of the Notch1 gene by deletion of its promoter in Ikaros-deficient T-ALL.
Jeannet R; Mastio J; Macias-Garcia A; Oravecz A; Ashworth T; Geimer Le Lay AS; Jost B; Le Gras S; Ghysdael J; Gridley T; Honjo T; Radtke F; Aster JC; Chan S; Kastner P
Blood; 2010 Dec; 116(25):5443-54. PubMed ID: 20829372
[TBL] [Abstract][Full Text] [Related]
5. [Notch activation during T-cell leukemogenesis in Ikaros-deficient mice].
Kastner P; Chan S
Med Sci (Paris); 2006; 22(8-9):708-10. PubMed ID: 16962043
[No Abstract] [Full Text] [Related]
6. Combined expression of pTalpha and Notch3 in T cell leukemia identifies the requirement of preTCR for leukemogenesis.
Bellavia D; Campese AF; Checquolo S; Balestri A; Biondi A; Cazzaniga G; Lendahl U; Fehling HJ; Hayday AC; Frati L; von Boehmer H; Gulino A; Screpanti I
Proc Natl Acad Sci U S A; 2002 Mar; 99(6):3788-93. PubMed ID: 11891328
[TBL] [Abstract][Full Text] [Related]
7. Expression of aberrantly spliced oncogenic ikaros isoforms in childhood acute lymphoblastic leukemia.
Sun L; Goodman PA; Wood CM; Crotty ML; Sensel M; Sather H; Navara C; Nachman J; Steinherz PG; Gaynon PS; Seibel N; Vassilev A; Juran BD; Reaman GH; Uckun FM
J Clin Oncol; 1999 Dec; 17(12):3753-66. PubMed ID: 10577847
[TBL] [Abstract][Full Text] [Related]
8. Ikaros represses the transcriptional response to Notch signaling in T-cell development.
Kleinmann E; Geimer Le Lay AS; Sellars M; Kastner P; Chan S
Mol Cell Biol; 2008 Dec; 28(24):7465-75. PubMed ID: 18852286
[TBL] [Abstract][Full Text] [Related]
9. Activated Notch counteracts Ikaros tumor suppression in mouse and human T-cell acute lymphoblastic leukemia.
Witkowski MT; Cimmino L; Hu Y; Trimarchi T; Tagoh H; McKenzie MD; Best SA; Tuohey L; Willson TA; Nutt SL; Busslinger M; Aifantis I; Smyth GK; Dickins RA
Leukemia; 2015 Jun; 29(6):1301-11. PubMed ID: 25655195
[TBL] [Abstract][Full Text] [Related]
10. Cell cycle-specific function of Ikaros in human leukemia.
Li Z; Song C; Ouyang H; Lai L; Payne KJ; Dovat S
Pediatr Blood Cancer; 2012 Jul; 59(1):69-76. PubMed ID: 22106042
[TBL] [Abstract][Full Text] [Related]
11. The tumor suppressor Ikaros shapes the repertoire of notch target genes in T cells.
Geimer Le Lay AS; Oravecz A; Mastio J; Jung C; Marchal P; Ebel C; Dembélé D; Jost B; Le Gras S; Thibault C; Borggrefe T; Kastner P; Chan S
Sci Signal; 2014 Mar; 7(317):ra28. PubMed ID: 24643801
[TBL] [Abstract][Full Text] [Related]
12. Notch target gene deregulation and maintenance of the leukemogenic phenotype do not require RBP-J kappa in Ikaros null mice.
Chari S; Umetsu SE; Winandy S
J Immunol; 2010 Jul; 185(1):410-7. PubMed ID: 20511547
[TBL] [Abstract][Full Text] [Related]
13. Protein phosphatase 1 (PP1) and Casein Kinase II (CK2) regulate Ikaros-mediated repression of TdT in thymocytes and T-cell leukemia.
Wang H; Song C; Gurel Z; Song N; Ma J; Ouyang H; Lai L; Payne KJ; Dovat S
Pediatr Blood Cancer; 2014 Dec; 61(12):2230-5. PubMed ID: 25214003
[TBL] [Abstract][Full Text] [Related]
14. Non-DNA-binding Ikaros isoform gene expressed in adult B-precursor acute lymphoblastic leukemia.
Nishii K; Katayama N; Miwa H; Shikami M; Usui E; Masuya M; Araki H; Lorenzo F; Ogawa T; Kyo T; Nasu K; Shiku H; Kita K
Leukemia; 2002 Jul; 16(7):1285-92. PubMed ID: 12094252
[TBL] [Abstract][Full Text] [Related]
15. Notch, a unifying target in T-cell acute lymphoblastic leukemia?
Screpanti I; Bellavia D; Campese AF; Frati L; Gulino A
Trends Mol Med; 2003 Jan; 9(1):30-5. PubMed ID: 12524208
[TBL] [Abstract][Full Text] [Related]
16. Ikaros inhibits megakaryopoiesis through functional interaction with GATA-1 and NOTCH signaling.
Malinge S; Thiollier C; Chlon TM; Doré LC; Diebold L; Bluteau O; Mabialah V; Vainchenker W; Dessen P; Winandy S; Mercher T; Crispino JD
Blood; 2013 Mar; 121(13):2440-51. PubMed ID: 23335373
[TBL] [Abstract][Full Text] [Related]
17. Perturbation of Ikaros isoform selection by MLV integration is a cooperative event in Notch(IC)-induced T cell leukemogenesis.
Beverly LJ; Capobianco AJ
Cancer Cell; 2003 Jun; 3(6):551-64. PubMed ID: 12842084
[TBL] [Abstract][Full Text] [Related]
18. Expression of a non-DNA-binding Ikaros isoform exclusively in B cells leads to autoimmunity but not leukemogenesis.
Wojcik H; Griffiths E; Staggs S; Hagman J; Winandy S
Eur J Immunol; 2007 Apr; 37(4):1022-32. PubMed ID: 17357110
[TBL] [Abstract][Full Text] [Related]
19. Notch3/Jagged1 circuitry reinforces notch signaling and sustains T-ALL.
Pelullo M; Quaranta R; Talora C; Checquolo S; Cialfi S; Felli MP; te Kronnie G; Borga C; Besharat ZM; Palermo R; Di Marcotullio L; Capobianco AJ; Gulino A; Screpanti I; Bellavia D
Neoplasia; 2014 Dec; 16(12):1007-17. PubMed ID: 25499214
[TBL] [Abstract][Full Text] [Related]
20. It's T-ALL about Notch.
Demarest RM; Ratti F; Capobianco AJ
Oncogene; 2008 Sep; 27(38):5082-91. PubMed ID: 18758476
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
